Grant: Travel Awards - Institute Community Support
Direct Payment
$1,000.00
Regulation of cell migration and integrin recycling by the endosomal adaptor GGA3
EF 2013-14
Résumé
Normal functioning of the human body and tissue formation requires a tight control of cues and signals sent from one cell to
another. A plethora of signals are interpreted by cell surface molecules called receptors and based on these signals, cells
respond in a variety of ways. Sometimes they promote growth or induce death but they can also promote a cell to move
through the body. This process occurs normally during embryonic development but also occurs in cancer in an uncontrolled
manner when a cell from a tumour metastasizes and colonizes another part of the body. Typically, the process of metastasis
is what ultimately leads to death in cancer patients. The molecules that the cell uses to adhere to its surroundings are called
integrins and are used when a cell migrates. When they are activated by signals, they are taken up within the cell and either
destroyed or transported to a surface of cell where it is needed. I propose that by elucidating the mechanisms that control
this decision between integrin destruction or recycling, we can understand how the cell controls movement and ultimately
use this for therapeutic benefit. I plan to investigate the molecules that control integrin transport inside the cell using state of
the art microscopic techniques, as well as established biochemical methods. This fundamental understanding is crucial for
our interpretation of clinical trials that are currently ongoing which use drugs that target integrins. The study that I propose
will be used to explain possible clinical outcomes and will ultimately aid in the rational improvement and refinement of
therapy.
Programme
Travel Awards - Institute Community Support
Bénéficiaire
Emplacement
Quebec, Canada
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
288461
Name
Ratcliffe Colin D
Region
Québec
Country
Canada
Orgtype
Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Institute of Cancer Research
Projecttitle
Regulation of cell migration and integrin recycling by the endosomal adaptor GGA3
Programtype2
Undefined
Orgnameinp2
Direct Payment
Cihramount2
$1,000
Cihrequipment2
$0
Programname2
Travel Awards - Institute Community Support
Keyworddelim
Biochemistry; Cancer; Cell Adhesion; Cell Biology; Cell Migration And Invasion; Confocal Microscopy; Endocytosis And Intracellular Trafficking; Live Cell Imaging
Abstract
Normal functioning of the human body and tissue formation requires a tight control of cues and signals sent from one cell to
another. A plethora of signals are interpreted by cell surface molecules called receptors and based on these signals, cells
respond in a variety of ways. Sometimes they promote growth or induce death but they can also promote a cell to move
through the body. This process occurs normally during embryonic development but also occurs in cancer in an uncontrolled
manner when a cell from a tumour metastasizes and colonizes another part of the body. Typically, the process of metastasis
is what ultimately leads to death in cancer patients. The molecules that the cell uses to adhere to its surroundings are called
integrins and are used when a cell migrates. When they are activated by signals, they are taken up within the cell and either
destroyed or transported to a surface of cell where it is needed. I propose that by elucidating the mechanisms that control
this decision between integrin destruction or recycling, we can understand how the cell controls movement and ultimately
use this for therapeutic benefit. I plan to investigate the molecules that control integrin transport inside the cell using state of
the art microscopic techniques, as well as established biochemical methods. This fundamental understanding is crucial for
our interpretation of clinical trials that are currently ongoing which use drugs that target integrins. The study that I propose
will be used to explain possible clinical outcomes and will ultimately aid in the rational improvement and refinement of
therapy.
Competitiondate
201305
Approvedterm2
0 yr 3 mths
Pinamesdelim
Ratcliffe, Colin D
Approvedterm
0 an 3 mois
Cihrcontribution2
Inst of Cancer Research~ $1,000~ $0~